shortagewatch

Home / Dermatologicals / Abrocitinib

ATC D11AH08 · Agents for Dermatitis, Excluding Corticosteroids · updated 2 Nov 2026

Abrocitinib shortage

As of 2 Nov 2026, Abrocitinib has a reported shortage in 1 of the 16 countries we track (Czechia), covering 1 product from 1 company.

Is there an Abrocitinib shortage?

Yes. As of 2 Nov 2026, Abrocitinib is reported short in 1 of the 16 countries we track: Czechia. The earliest expected return is 31 Dec 2026 (Czechia).

Countries1/16
Products1packs or presentations
Companies11 listed
Short since30 Apr 20242.5 years ago
Earliest return31 Dec 2026company estimate
Main reasonCommercial decision or withdrawal
United StatesNo reported shortageCanadaNo reported shortageGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechia1 product shortNorwayNo reported shortageSwedenNo reported shortageJapanNo reported shortageNew ZealandNo reported shortageAustraliaNo reported shortage

Timeline

Czechia
202520262027CIBINQO 50MG 50MG TBL FLM 28CIBINQO 50MG 50MG TBL FLM 28today

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Which companies are short

products short, all countries
Pfizer1 PFE

Listed: Pfizer PFE · NYSE

Compared with similar medicines

ATC group D11AH · Agents for Dermatitis, Excluding Corticosteroids
Pimecrolimus2/16Tacrolimus2/16Abrocitinib1/16Alitretinoin1/16Cromoglicic Acid1/16

Affected products

CountryProductCompanySinceExpected backReason
CZCIBINQO 50MG 50MG TBL FLM 28Pfizer Europe MA EEIG, Bruxelles30 Apr 202431 Dec 2026Commercial decision or withdrawal
Obchodní/marketingové důvody

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.

Questions

Is there an Abrocitinib shortage?

Yes. As of 2 Nov 2026, Abrocitinib is reported short in 1 of the 16 countries we track: Czechia. The earliest expected return is 31 Dec 2026 (Czechia).

When will Abrocitinib be back in stock?

Companies expect supply back from 31 Dec 2026 in Czechia; Czechia: 31 Dec 2026. These are company estimates reported to each authority.

Why is Abrocitinib in short supply?

The most common reason reported is: commercial decision or withdrawal. Reasons by product are listed in the table below.

Which companies have Abrocitinib shortages?

Pfizer.